Delivery of siRNA using cationic rosette nanotubes for gene silencing
Uyen Ho1,2, Mounir El-Bakkari1,2, Aws Alshamsan2,3
1Department of Chemistry, University of Alberta, 11227 Saskatchewan Drive Edmonton, Alberta, T6G 2G2, Canada.
Biomaterials Science
|September 21, 2023
Summary
Rosette nanotubes (RNTs) effectively deliver small interfering RNA (siRNA) for gene silencing. These DNA nanostructures protect siRNA from degradation and enhance cellular uptake, reducing target protein expression by approximately 70%.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Molecular Biology
- Gene Therapy
Background:
- RNA interference (RNAi) and gene silencing offer therapeutic potential for hereditary diseases.
- Effective delivery strategies are crucial for reducing toxicity and increasing silencing efficiency in RNAi.
- Rosette nanotubes (RNTs), self-assembled from guanine-cytosine DNA, are promising biomimetic nanostructures.
Purpose of the Study:
- To investigate the use of bioactive RNTs for small interfering RNA (siRNA) delivery and gene silencing.
- To synthesize and characterize lysine-functionalized RNTs (KnT) for enhanced siRNA complexation and cellular uptake.
- To evaluate the efficiency of KnT RNTs in delivering siRNA and achieving gene silencing in cancer cell lines.
Main Methods:
- Synthesis of fifteen lysine-functionalized twin-G∧C motifs (KnT, n = 1 to 15) using solid-phase peptide synthesis.
- Self-assembly of KnT motifs into cationic RNTs under physiological conditions.
- Assessment of siRNA complexation and intracellular uptake mediated by KnT RNTs in HCT116 and A549 cells.
- Gene expression analysis to quantify the reduction in target stat3 protein expression.
Main Results:
- Cationic RNTs were successfully formed from lysine-functionalized G∧C motifs.
- KnT RNTs demonstrated efficient siRNA complexation, influenced by cationic charge and RNT length.
- Higher charged KnT RNTs facilitated faster siRNA cellular uptake via the endocytic pathway.
- KnT RNTs protected siRNA from serum degradation, leading to significant stat3 protein expression reduction (~70%).
Conclusions:
- Lysine-functionalized rosette nanotubes (KnT RNTs) represent an effective and biomimetic platform for siRNA delivery.
- The cationic nature and self-assembly properties of KnT RNTs enhance siRNA uptake and gene silencing efficiency.
- This approach shows promise for developing safer and more effective gene silencing therapies for hereditary diseases.
Related Concept Videos
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Small interfering RNAs (siRNA)
3.6K
3.6K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K


